The invention relates to substituted arylsulphonylaminomethylphosphonic acid derivatives of general formula (I) wherein the groups R
a
to R
f
, A and Z are defined as mentioned in the specification and claims, which are suitable for preparing a medicament for the treatment of metabolic disorders, particularly type 1 or type 2 diabetes mellitus.
本发明涉及一种通式(I)的取代芳基磺酰
氨甲基膦酸衍
生物,其中R到Rf,A和Z的基团如说明书和权利要求中所述,适用于制备用于治疗代谢性疾病,特别是1型或2型糖尿病的药物。